Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes
Sung H, Ferlay J, Siegel RL, et al
Int J Mol Sci 25(24):13438 33.Heinla K, Vasar E, Reppo I, Sedman T, Volke V (2023) GLP-1 receptor agonists induce growth hormone secretion in healthy volunteers
Study-defined categories for the index medication were monotherapy (only drug of interest initiated), combination therapy (simultaneous initiation with another drug of interest), add-on therapy (initiation in addition to existing drug of interest), switched-to therapy (replacement of drug of interest), simultaneous add-on and switched-to therapy, and nonevaluable index therapy
Por lo general, no se recomienda el uso de GLP-1 a las personas que: Padece problemas gastrointestinales graves, como gastroparesia Padece intolerancia o alergia a los GLP-1 Est embarazada o en periodo de lactancia Tiene antecedentes personales o familiares de formas raras de cncer de tiroides denominadas cncer medular de tiroides o neoplasia endocrina mltiple tipo 2 La salud mental es un factor importante que debe tenerse en cuenta antes de iniciar un tratamiento con medicamentos de GLP-1
